Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis

Back

ESC Professional Premium Access

Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis

Session: Risk prediction and treatment options in cardio-oncology

Topic: Cardio-Oncology

Speaker: Assistant Professor L. Liu (Hsinchu, TW)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Assistant Professor Lawrence Yu-Min Liu

Hsinchu MacKay Memorial Hospital, Hsinchu (Taiwan)

0 follower

4 more presentations in this session

Adverse cardiovascular events in patients with cancer: a biomarker-enhanced clinical risk score

Speaker: Doctor S. Kraler (Baden, CH)

Sex differences in cancer incidence amongst people with cardiovascular disease: a large British population study.

Speaker: Miss R. Thuemmler (Aberdeen, GB)

An analysis of the virtual cardio-oncology research initiative (VICORI) resource: bleeding risk among cancer patients beyond 1-year post-myocardial infarction

Speaker: Doctor K. Ow (Leicester, GB)

Unveiling the heartbeat of hope: exploring cardiovascular morbidity, mortality, and socioeconomic threads in 65,173 Child, Adolescent, and Young Adult (caya) cancer patients.

Speaker: Doctor J. Sodling (Norrkoping, SE)

Access the full session

Risk prediction and treatment options in cardio-oncology

Speakers: Assistant Professor L. Liu, Doctor S. Kraler, Miss R. Thuemmler, Doctor K. Ow, Doctor J. Sodling

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources